| 2000 |
GIT2 (including both long and short splice variants) possesses ARF GTPase-activating protein (ARF-GAP) activity toward ARF1 in vitro, interacts with G protein-coupled receptor kinase 2 (GRK2), and interacts with PIX-PAK complexes. The longest GIT2 variant inhibits beta2-adrenergic receptor sequestration when overexpressed, whereas the shortest splice variant is inactive in this assay. |
In vitro GAP assay, co-immunoprecipitation, cellular overexpression with receptor sequestration readout |
The Journal of biological chemistry |
High |
10896954
|
| 2001 |
GIT2/PKL (paxillin kinase linker) interacts with paxillin via the paxillin LD4 motif; this interaction is required for PKL localization to focal contacts and for normal Rac-dependent cell spreading and directional motility. Loss of the paxillin-PKL interaction leads to prolonged Rac activation, multiple broad lamellipodia, and impaired directional motility without affecting FAK activity. |
Overexpression of deletion mutants (paxillinΔLD4, PKLδPBS2) in CHO.K1 fibroblasts; immunofluorescence localization; cell spreading/motility assays; Rac activity measurements |
The Journal of cell biology |
High |
11448998
|
| 2001 |
GIT2-short (KIAA0148), a short isoform of GIT2, co-localizes with paxillin at perinuclear areas and acts as an ARF-GAP for ARF1 in vivo. Overexpression of wild-type GIT2-short (but not its GAP-inactive mutant) redistributes Golgi protein β-COP, reduces focal adhesions and actin stress fibers, and alters perinuclear paxillin localization, demonstrating that the ARF-GAP catalytic activity is required for these effects. |
Overexpression and GAP-inactive mutant rescue in cells; immunofluorescence co-localization; Golgi distribution assay; focal adhesion and actin stress fiber quantification |
Molecular biology of the cell |
High |
11251077
|
| 2001 |
PAK1, PIX (β-PIX), and p95PKL (GIT2) form a stable trimolecular complex in T cells. This complex is activated downstream of the T-cell receptor via ZAP-70/Syk kinases and a LAT/Slp-76-independent pathway; PIX GEF activity within the complex is required for Rho GTPase activation upstream of PAK1. |
Co-immunoprecipitation demonstrating trimolecular complex; dominant-negative PIX overexpression; TCR stimulation assays with kinase inhibitors and adaptor-deficient Jurkat cells |
The EMBO journal |
High |
11157752
|
| 2003 |
CrkII/CrkL adapter proteins associate with a Paxillin/GIT2/β-PIX complex; this association promotes Rac-dependent relocalization of paxillin to focal contacts and lamellipodia formation. Paxillin mutants unable to associate with Crk or GIT2 block Crk-dependent cell spreading. |
Co-immunoprecipitation; stable cell line overexpression; dominant-negative Crk mutants; Rac inhibition; immunofluorescence localization |
Molecular biology of the cell |
High |
12857867
|
| 2006 |
Endogenous GIT2 represses lamellipodial extension via Rac1-dependent signaling and represses focal adhesion turnover via Cdc42-dependent signaling. GIT2 knockdown is sufficient to induce migration of non-transformed MCF10A epithelial cells. The SH2-SH3 adaptor Crk is identified as an essential downstream target of GIT2 inhibition, whereas β-PIX is dispensable for GIT2-mediated effects. |
siRNA knockdown of endogenous GIT2; lamellipodia and FA turnover assays; epistasis with Rac1, Cdc42, Crk, and β-PIX |
The EMBO journal |
High |
16628223
|
| 2006 |
GIT2 is required in neutrophils for directional chemotaxis and for suppression of superoxide production in response to G protein-coupled receptor stimulation. GIT2 suppresses ARF1 activity and functions downstream of Gβγ subunits in the direction-sensing machinery. Loss of GIT2 in vivo leads to an immunodeficient state. |
GIT2-knockout mouse neutrophils; directional chemotaxis assays; superoxide production measurements; epistasis placing GIT2 downstream of Gβγ and upstream of ARF1 |
Nature immunology |
High |
16715100
|
| 2010 |
GIT2 is required for efficient thymocyte positive selection. Git2-/- double-positive thymocytes show elevated Rac GTPase activation, increased actin polymerization, and enhanced chemokine-directed migration in vitro. Two-photon microscopy revealed that scanning activity of Git2-/- thymocytes was compromised in the thymic cortex, indicating GIT2 negatively regulates Rac-mediated chemotactic motility in thymocytes. |
Git2-knockout mice; Rac activation assay; actin polymerization assay; in vitro chemotaxis; two-photon laser-scanning microscopy in intact thymus |
Nature immunology |
High |
20431621
|
| 2010 |
Zebrafish Git2a is required for cell movements during gastrulation; its depletion arrests directed cell migration toward the vegetal pole and reduces cell contractility. Git2a regulates phosphorylation of myosin light chain (MLC), thereby controlling myosin II-mediated cell contractility. The phenotype is rescued by chicken GIT2, confirming functional conservation. |
Antisense morpholino knockdown; time-lapse microscopy; myosin light chain phosphorylation assay; pharmacological inhibition with Blebbistatin; rescue with chicken GIT2 |
Developmental biology |
High |
21034731
|
| 2013 |
PKL/GIT2 regulates activity of the Rac1 GEF Vav2 through a phosphorylation-dependent interaction. PKL is required for Vav2 activation downstream of integrin engagement and EGF stimulation. Vav2 in turn regulates redistribution of PKL and β-PIX to focal adhesions after EGF stimulation, forming a feedforward signaling loop. Vav2 knockdown reduces directional persistence and polarization of migrating cells. |
Co-immunoprecipitation; PKL and Vav2 knockdown; Rac1 activation assays; immunofluorescence localization of PKL and β-PIX; cell migration directionality assays |
Molecular biology of the cell |
High |
23615439
|
| 2013 |
Loss of Git2 promotes epithelial-mesenchymal transition (EMT) through a pathway involving enhanced maturation of miR-146a, which suppresses Cnot6L (a deadenylase), leading to stabilization of Zeb1 mRNA and increased Zeb1 expression. |
Git2 knockdown/knockout; miR-146a maturation assay; Cnot6L manipulation; Zeb1 mRNA stability assay; EMT marker analysis |
Journal of cell science |
Medium |
23591815
|
| 2014 |
GIT2 negatively regulates TLR-induced NF-κB and MAPK signaling by recruiting the deubiquitinating enzyme Cylindromatosis (CYLD) to inhibit K63-linked ubiquitination of TRAF6, thereby terminating downstream inflammatory signaling. Git2-deficient mice and macrophages show dramatically increased pro-inflammatory cytokine production in response to TLR stimulation. |
Git2-knockout mice and macrophages; TLR stimulation assays; NF-κB and MAPK activation measurements; Co-immunoprecipitation of GIT2-CYLD complex; TRAF6 ubiquitination assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
24879442
|
| 2015 |
GIT2 localizes to the nucleus, is phosphorylated by ATM kinase following DNA damage, and forms complexes with multiple DNA damage response (DDR) factors. GIT2 targeting to DNA double-strand breaks depends on H2AX, ATM, and MRE11 but is independent of MDC1 and RNF8. GIT2 promotes DNA repair by stabilizing BRCA1 in repair complexes, upregulating HMGN1 and RFC1, and regulating PARP activity. GIT2-knockout mice show increased susceptibility to irradiation-induced DNA damage. |
Nuclear fractionation; Co-immunoprecipitation with DDR factors; ATM kinase phosphorylation assay; DDR factor dependency analysis (H2AX/ATM/MRE11/MDC1/RNF8); GIT2-KO mice irradiation; PARP activity assay; immunofluorescence foci analysis |
Molecular and cellular biology |
High |
25605334
|
| 2016 |
GIT2 restricts focal adhesion recruitment of DOCK5 and inhibits DOCK5 interaction with Crk, thereby suppressing DOCK5-dependent activation of the Crk-p130Cas signaling cascade, Rac1-mediated lamellipodial protrusion, and FA turnover. GIT2 is recruited to focal adhesions in response to Rho-ROCK signaling and actomyosin contractility. |
GIT2 knockdown/overexpression; Co-immunoprecipitation of GIT2-DOCK5-Crk interactions; ROCK and MLC inhibition; Rac1 activation assay; invasion assays in epithelial cells |
Oncogene |
High |
27669437
|
| 2016 |
RUSC2 interacts with the Spa Homology Domain (SHD) of GIT2 in lung cancer cells, stabilizes GIT2 by decreasing its degradation and increasing its phosphorylation, and promotes Golgi reorientation and directional migration. EGF stimulation transiently increases RUSC2-GIT2 interaction, while prolonged EGF stimulation decreases it via Rab35 activation. Rab35 silencing reduces GIT2 stability and phosphorylation. |
Co-immunoprecipitation (RUSC2-GIT2 interaction); RUSC2 and Rab35 silencing; GIT2 stability assays; Golgi reorientation assay; directional migration assay |
Cancer letters |
Medium |
27238570
|
| 2016 |
GIT2 physically interacts with the insulin receptor and insulin receptor substrate 2 (IRS-2) in pancreatic tissue; this interaction is diminished in diabetic db/db mice. Genomic deletion of GIT2 disrupts pancreatic beta cell mass and reduces insulin secretion, leading to elevated plasma glucose and insulin resistance. |
Co-immunoprecipitation of GIT2 with insulin receptor and IRS-2; GIT2-KO mouse metabolic phenotyping; pancreatic islet transcriptomics |
Frontiers in endocrinology |
Medium |
26834700
|
| 2018 |
GIT2/PKL mediates endothelial progenitor cell (EPC) migration downstream of CXCR2 via the Src-PKL/Vav2-Rac1 signaling pathway. Phosphorylation and co-localization of PKL and Vav2 are required for Rac1 activation and development of lamellipodia/filopodia driving EPC migration. |
Transwell migration assays; shRNA knockdown; signaling inhibitors; immunofluorescence co-localization of PKL and Vav2; Rac1 phosphorylation assays |
FASEB journal |
Medium |
29229683
|
| 2024 |
GIT2 associates with centrosomes and γ-tubulin complex proteins in mast cells. Depletion of GIT2 enhances centrosomal microtubule nucleation. Phosphorylation of GIT2 by conventional protein kinase C (PKC) promotes its centrosomal localization and microtubule nucleation during FcεRI-induced activation. GIT2 (unlike GIT1) acts as a negative regulator of microtubule nucleation in mast cells and also participates in antigen-induced degranulation and chemotaxis. |
shRNA depletion; immunofluorescence and Co-IP with γ-tubulin complex proteins; time-lapse microtubule nucleation assay; PKC inhibitor treatment; site-directed mutagenesis of phosphorylation sites; phenotypic rescue |
Frontiers in immunology |
High |
38370406
|
| 2025 |
GIT2 directly binds NF-κB components p65 (canonical) and p52 (non-canonical) to inhibit their activation, and positively regulates TRAF3 expression to further suppress both canonical and non-canonical NF-κB signaling. GIT2 thereby promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and alleviates DNA damage-induced cellular senescence. |
Co-immunoprecipitation (GIT2 with p65 and p52); Western blotting of NF-κB pathway components; GIT2 overexpression/knockdown in BMSCs; comet assay; in vivo ovariectomy mouse model; micro-CT bone analysis |
Tissue & cell |
Medium |
39954559
|
| 2025 |
THRAP3 recruits the splicing factor SLU7 to facilitate skipping of GIT2 Exon14, generating a GIT2 splice variant that promotes ferroptosis resistance in AML cells by inhibiting iron accumulation and promoting GSH synthesis. Inhibition of GIT2 Exon14 skipping reverses THRAP3-induced ferroptosis resistance in vitro and in vivo. |
THRAP3 knockdown/overexpression; Co-immunoprecipitation of THRAP3-SLU7; RT-PCR/splicing assays for Exon14; ferroptosis assays (RSL3/erastin); iron and GSH measurement; orthotopic mouse models |
Nature communications |
Medium |
41326370
|
| 2025 |
In glioblastoma cells, GIT2 associates with γ-tubulin ring complex (γTuRC) proteins and localizes to centrosomes. Depletion of GIT2 enhances centrosomal microtubule nucleation. The N-terminal ArfGAP domain of GIT2 is responsible for centrosomal localization and regulation of microtubule nucleation. PKC phosphorylates GIT2 at serine 46 (S46) on the ArfGAP domain, and phosphomimetic S46 promotes microtubule nucleation. |
shRNA depletion; immunofluorescence; time-lapse microtubule nucleation; immunoprecipitation with γTuRC components; site-directed mutagenesis (S46); kinase assay with PKC inhibitors |
Cancer cell international |
High |
40176062
|